What MDLifespan’s plasma exchange expansion reveals about toxin burden and aging medicine
Find out how MDLifespan and Cenegenics are redefining plasma exchange for inflammation and toxin removal. Could this reshape preventive health care?
Resolve M Therapeutics exits stealth with Johnson & Johnson Innovation support to pursue MS1-driven immune resolution
Resolve M exits stealth with a bold MS1-based approach to inflammation. Learn how its pro-resolution platform could reshape autoimmune drug development.